<- Go Home
Bruker Cellular Analysis, Inc.
Bruker Cellular Analysis, Inc. operates as a functional cell biology company. The company enables scientists to reveal insights into cell function and obtain the behavior of each cell. Its suite of tools and services offers unparalleled resolution and speed, accelerating insights and advancing discoveries that can profoundly improve the prevention and treatment of disease. The company’s platforms are used by researchers worldwide, including pharmaceutical companies and comprehensive cancer centers. The company was formerly known as PhenomeX Inc. and changed its name to Bruker Cellular Analysis, Inc. in October 2023. The company was incorporated in 2011 and is based in Emeryville, California with an additional office in Branford, Connecticut. As of September 29, 2023, Bruker Cellular Analysis, Inc. operates as a subsidiary of Bruker Corporation.
Market Cap
$99.6M
Volume
801.5K
Cash and Equivalents
$31.0M
EBITDA
-$88.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$46.5M
Profit Margin
64.75%
52 Week High
$3.65
52 Week Low
$0.38
Dividend
N/A
Price / Book Value
0.89
Price / Earnings
-0.63
Price / Tangible Book Value
1.11
Enterprise Value
$97.6M
Enterprise Value / EBITDA
-1.21
Operating Income
-$98.8M
Return on Equity
87.18%
Return on Assets
-28.93
Cash and Short Term Investments
$31.0M
Debt
$29.0M
Equity
$111.3M
Revenue
$71.8M
Unlevered FCF
-$43.6M
Sector
Life Sciences Tools and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium